ataxxa 200 mg/40 mg
krka, d.d., novo mesto, slovēnija - imidaclopridum, permethrinum - šķīdums pilināšanai uz ādas - suņi līdz 4 kg
otopet therapy ausu pilieni, suspensija
fatro s.p.a., itālija - rifaximin, colistin sulfate, miconazole, triamcinolone acetonide, carbaril - ausu pilieni, suspensija - kaķi; suņi
amoksiklav 62,5% ūdenī šķīstošs pulveris
elanco gmbh, vācija - amoksicilīna trihidrāts,clavulanate potassium - ūdenī šķīstošs pulveris - cūkas
vitamin b1 sopharma 80 mg/2 ml šķīdums injekcijām
sopharma ad, bulgaria - thiamini hydrochloridum - Šķīdums injekcijām - 80 mg/2 ml
rabakir 300 mg cietās kapsulas
gedeon richter plc., hungary - pregabalīns - cietās kapsulas - 300 mg
rabakir 150 mg cietās kapsulas
gedeon richter plc., hungary - pregabalīns - cietās kapsulas - 150 mg
rabakir 75 mg cietās kapsulas
gedeon richter plc., hungary - pregabalīns - cietās kapsulas - 75 mg
rabakir 25 mg cietās kapsulas
gedeon richter plc., hungary - pregabalīns - cietās kapsulas - 25 mg
skyrizi
abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - imūnsupresanti - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.
horstem
equicord s.l. - zirgu nabas mezenhimālas cilmes šūnas - other drugs for disorders of the musculo-skeletal system - zirgi - samazinājums klibumu, kas saistīti ar vieglas līdz vidēji deģeneratīvas locītavu slimības (osteoartrīta) zirgiem.